Show simple item record

dc.contributor.authorLamos, E.M.
dc.contributor.authorWijesinha, M.A.
dc.contributor.authorRamhmdani, S.
dc.date.accessioned2019-11-01T12:49:36Z
dc.date.available2019-11-01T12:49:36Z
dc.date.issued2017
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85009865567&doi=10.2147%2fDMSO.S118437&partnerID=40&md5=7d5945b1ee1dc4a454eeea7e5a5053c1
dc.identifier.urihttp://hdl.handle.net/10713/11301
dc.description.abstractObjective: To compare length of stay (LOS) and incidence of hypoglycemic events and infections in hospitalized patients with diabetes mellitus (DM) undergoing renal transplantation, among groups of patients defined by admission glucose and mean inpatient daily glucose. Methods: A retrospective analysis of 190 charts of patients with DM who underwent renal transplantation over a 2-year period was conducted. Patients were grouped according to admission glucose and mean inpatient daily glucose (≤140 mg/dL, 141–180 mg/dL, and >180 mg/dL). Results: Admission glucose was not associated with LOS. A mean inpatient daily glucose of ≤140 mg/dL was associated with a longer LOS compared to a mean inpatient daily glucose of >180 mg/dL (p=0.03). Patients with an admission glucose of ≤140 mg/dL had approximately half the rate of hypoglycemic events compared to those with admission glucose of 141−180 mg/dL (odds ratio [OR]=2.1; p=0.02) or >180 mg/dL (OR=1.9; p=0.04). However, patients whose mean daily glucose was ≤140 mg/dL had approximately twice the rate of hypoglycemic events than those whose mean daily glucose was 141−180 mg/dL (OR=0.4; p=0.01) or >180 mg/dL (OR=0.4; p=0.004). The incidence of infections was low and was not associated with admission or mean daily glucose levels. Conclusion: Lower mean daily inpatient glucose levels (≤140 mg/dL) are associated with longer LOS and greater incidence of hypoglycemic episodes in diabetes patients undergoing renal transplantation. Our findings suggest that target blood glucose levels of 140−180 mg/dL may be appropriate in this specific population. Additional prospective research is needed to confirm these findings. Copyright 2017 Lamos et al.en_US
dc.description.sponsorshipThis work was supported by American Diabetes Association grant #1-08-CR-60 (KS).en_US
dc.description.urihttps://doi.org/10.2147/DMSO.S118437en_US
dc.language.isoen_USen_US
dc.publisherDove Medical Press Ltd.en_US
dc.relation.ispartofDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy
dc.subjectDiabetes mellitusen_US
dc.subjectHypoglycemiaen_US
dc.subjectInfectionen_US
dc.subjectLength of stayen_US
dc.subjectRenal transplantationen_US
dc.titleRole of glycemic control on hospital-related outcomes in patients with diabetes mellitus undergoing renal transplantationen_US
dc.typeArticleen_US
dc.identifier.doi10.2147/DMSO.S118437


This item appears in the following Collection(s)

Show simple item record